Large-cohort screening projects in seven regions of China demonstrate the efficacy of extended HPV genotyping in triaging HPV-positive women - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Extensive screening initiatives across seven regions in China highlight the effectiveness of advanced HPV genotyping for managing HPV-positive women.

  • By

  • Wenkui Dai

  • Yu Liu

  • Hui Du

  • Chunlei Guo

  • Di Wu

  • Xin Jiang

  • Shuai Cheng Li

  • Changzhong Li

  • Xinfeng Qu

  • Ruifang Wu

  • September 14, 2026

Share

  • 1

    HPV infection is the primary risk factor for cervical intraepithelial neoplasia and invasive cervical cancer.

  • 2

    The World Health Organization recommends HPV DNA testing as a screening modality for cervical cancer prevention.

  • 3

    Extended high-risk HPV genotyping offers a standardized approach to risk stratification in cervical cancer screening.

  • 4

    The study pooled data from five population-based screening projects and analyzed high-risk HPV genotyping results from self-collected specimens.

  • 5

    Investigators analyzed genotype-specific high-risk HPV infections and their associations with histologically confirmed CIN3+ lesions.

Original Source(s)

Related Content